The purpose of this study is to test a novel diagnostic immunoassay of platelet function and compare it to the current gold standard platelet function assay by testing the response to aspirin and clopidogrel in a group of healthy volunteers and severely obese individuals and comparing the accuracy of the two tests. The secondary goals will be to evaluate the pharmacodynamic parameters of the antiplatelet agents across the two testing modalities and refine the cutoffs used for the novel assay.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
112
Low dose aspirin in Arms A and D and High Dose Aspirin in Arm B
Arms C and E
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Comparison at day 5 of pDrp1 Assay relative to Light Transmission Aggregometry
Sensitivity of pDrp1 assay for platelet inhibition at day 5
Time frame: 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.